Thus, the BNIP3 promoter is methylated in colorectal carcinoma [18], pancreas adenocarcinoma [19], several types of hematopoietic tumors [20] and BNIP3 re-expression by methyltransferase inhibitor restored hypoxia-inducible cell death. Here, BNIP3 is linked to pancreatic adenocarcinoma.